<VariationArchive VariationID="1709559" VariationName="NM_001128178.3(NPHP1):c.480dup (p.Gly161fs)" VariationType="Duplication" Accession="VCV001709559" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2022-10-15" MostRecentSubmission="2022-10-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1707913" VariationID="1709559">
      <GeneList>
        <Gene Symbol="NPHP1" FullName="nephrocystin 1" GeneID="4867" HGNC_ID="HGNC:7905" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="110123348" stop="110205013" display_start="110123348" display_stop="110205013" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="110880912" stop="110962638" display_start="110880912" display_stop="110962638" Strand="-" />
          </Location>
          <OMIM>607100</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001128178.3(NPHP1):c.480dup (p.Gly161fs)</Name>
      <CanonicalSPDI>NC_000002.12:110169847:AA:AAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="110169847" stop="110169848" display_start="110169847" display_stop="110169848" variantLength="1" positionVCF="110169847" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="110927424" stop="110927425" display_start="110927424" display_stop="110927425" variantLength="1" positionVCF="110927424" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>G161fs</ProteinChange>
      <ProteinChange>G99fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.110927426dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.110927426dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.110169849dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.110169849dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008287.1" sequenceAccession="NG_008287" sequenceVersion="1" change="g.40215dup">
            <Expression>NG_008287.1:g.40215dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000272.5" sequenceAccession="NM_000272" sequenceVersion="5" change="c.480dup">
            <Expression>NM_000272.5:c.480dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000263.2" sequenceAccession="NP_000263" sequenceVersion="2" change="p.Gly161fs">
            <Expression>NP_000263.2:p.Gly161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128178.3" sequenceAccession="NM_001128178" sequenceVersion="3" change="c.480dup" MANESelect="true">
            <Expression>NM_001128178.3:c.480dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121650.1" sequenceAccession="NP_001121650" sequenceVersion="1" change="p.Gly161fs">
            <Expression>NP_001121650.1:p.Gly161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128179.3" sequenceAccession="NM_001128179" sequenceVersion="3" change="c.294dup">
            <Expression>NM_001128179.3:c.294dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121651.1" sequenceAccession="NP_001121651" sequenceVersion="1" change="p.Gly99fs">
            <Expression>NP_001121651.1:p.Gly99fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374256.1" sequenceAccession="NM_001374256" sequenceVersion="1" change="c.480dup">
            <Expression>NM_001374256.1:c.480dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361185.1" sequenceAccession="NP_001361185" sequenceVersion="1" change="p.Gly161fs">
            <Expression>NP_001361185.1:p.Gly161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374257.1" sequenceAccession="NM_001374257" sequenceVersion="1" change="c.480dup">
            <Expression>NM_001374257.1:c.480dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361186.1" sequenceAccession="NP_001361186" sequenceVersion="1" change="p.Gly161fs">
            <Expression>NP_001361186.1:p.Gly161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_207181.4" sequenceAccession="NM_207181" sequenceVersion="4" change="c.480dup">
            <Expression>NM_207181.4:c.480dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_997064.2" sequenceAccession="NP_997064" sequenceVersion="2" change="p.Gly161fs">
            <Expression>NP_997064.2:p.Gly161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001128178.3(NPHP1):c.480dup (p.Gly161fs) AND Nephronophthisis 1" Accession="RCV002289374" Version="2">
        <ClassifiedConditionList TraitSetID="911">
          <ClassifiedCondition DB="MedGen" ID="C1855681">Nephronophthisis 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-10-15" MostRecentSubmission="2022-10-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="911" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3445" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nephronophthisis familial juvenile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 1</ElementValue>
                <XRef ID="21201" DB="GeneTests" />
                <XRef ID="Nephronophthisis+1/5141" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009728" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHP1</ElementValue>
                <XRef Type="MIM" ID="256100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NPH1</ElementValue>
                <XRef Type="MIM" ID="256100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18645" />
                <XRef ID="18645" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="93592" DB="Orphanet" />
              <XRef ID="C1855681" DB="MedGen" />
              <XRef ID="MONDO:0009728" DB="MONDO" />
              <XRef Type="MIM" ID="256100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5042741" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_001128178.3:c.480dup|OMIM:256100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002580195" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001128178.3:c.480dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="256100" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PM2_SUP, PM3_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5042741" TraitType="Disease" MappingType="XRef" MappingValue="256100" MappingRef="OMIM">
        <MedGen CUI="C1855681" Name="Nephronophthisis 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

